Form 4 for HAE HAEMONETICS CORP
Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0001127602-24-016164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-21 | 2024-05-17+ | HAE | Basil Michelle L | EVP, GC | S - Sale | $95.05 | -2,677 | 29.4K | -8% | -$254.4K |
| D | 2024-05-21 | 2024-05-17 | HAE | Basil Michelle L | EVP, GC | A - Grant | — | +4,178 | 32.9K | +15% | — |
| D | 2024-05-21 | 2024-05-17 | HAE | Basil Michelle L | EVP, GC | F - Tax | $95.73 | -669 | 28.7K | -2% | -$64.0K |
| D | 2024-05-21 | 2024-05-17 | HAE | Basil Michelle L | EVP, GC | A - Grant | $0.00 | +9,183 | 9,183 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-20 | S | D | 1,604 | $95.08 | 31,257 | D | — | — | (F2) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 2 | Common | Common Stock | 2024-05-17 | A | A | 4,178 | — | 32,861 | D | — | — | (F4) The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. (F5) Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. (F2) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 3 | Common | Common Stock | 2024-05-17 | F | D | 669 | $95.73 | 28,683 | D | — | — | (F3) Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I. (F2) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 4 | Common | Common Stock | 2024-05-17 | S | D | 1,073 | $95.00 | 29,352 | D | — | — | (F2) This number includes unvested restricted stock units ("RSUs") previously reported. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-05-17 | A | A | 9,183 | $0.00 | 9,183 | D | $95.73 · — to 2031-05-17 | 9,183 Common Stock | (F6) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |